Effect of PVE on Surgical Outcomes and Long-term Survival in Perihilar Cholangiocarcinoma
NCT ID: NCT06222619
Last Updated: 2024-01-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
136 participants
OBSERVATIONAL
2020-01-30
2023-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of PVE on Patient's Long-term Survival, Complications and Cancer Recurrence.
NCT03168230
Portal Vein Embolization in Treating Patients With Liver Metastases From Primary Colorectal Cancer
NCT00028626
Clinical Outcomes of Preservation Versus Resection of Portal/Superior Mesenteric Vein During Pancreaticoduodenectomy in Pancreatic Cancer Patients Who Respond to Neoadjuvant Treatment
NCT06372886
Perioperative vs Postoperative Chemotherapy + Bevacizumab in Colorectal Cancer, Liver Mets
NCT01632722
Prognostic Value Related to the Presence of Thrombosis or Portal Vein Invasion in Patients With Hepatocellular Carcinoma Submitted to Surgery
NCT01690715
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Resection without PVE
Resection of bile duct and associated hemi-liver without portal vein embilzation
No interventions assigned to this group
Resection after PVE
Resection of bile duct and associated hemi-liver after portal vein embilzation
Potal vein embilization
Portal vein of involved bile duct is embolized to increase the volume of remnant liver.
No resection after PVE
No resection of bile duct and associated hemi-liver after portal vein embilzation
Potal vein embilization
Portal vein of involved bile duct is embolized to increase the volume of remnant liver.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Potal vein embilization
Portal vein of involved bile duct is embolized to increase the volume of remnant liver.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. patients with perihilar cholangiocarcinoma histologically confirmed by surgical resection or forceps biopsy/brush cytology under endoscopic retrograde cholangiopancreatography or through the percutaneous transhepatic biliary drainage tract.
Exclusion Criteria
2. patients who refused treatment
3. patients with other concomitant malignancies.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sang Hyub Lee
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National University Hospital
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-2001-092-1095
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.